BIEMANS, BARBARA,GUBA, WOLFGANG,JAESCHKE, GEORG,LINDEMANN, LOTHAR,O,HARA, FIONN,RICCI, ANTONIO,RUEHER, DANIEL,VIEIRA, ERIC
申请号：
RSP20190819
公开号：
RS58929B1
申请日:
2016.07.11
申请国别(地区):
RS
年份:
2019
代理人:
摘要：
The present invention relates to positive allosteric modulators (PAMs) of metabotropic glutamate receptor 4 (mGluR4) that may be used for the treatment of conditions such as Parkinson's disease, anxiety, emesis, obsessive compulsive disorder, autism, neuroprotection, cancer, depression and diabetes type 2.
